Hematology, Oncology & Immunology · Topic 17 of 26

Hyperviscosity & Leukostasis

Hematology-oncology · oncologic emergency

Hyperviscosity & Leukostasis

Thick blood starves the brain and lungs: blasts over 100,000/µL need cytoreduction now; a symptomatic paraprotein needs plasma exchange.

Key numbers

Hyperleukocytosis: WBC above 100,000/µLWBC > 100,000/µL

Urgent plasma exchange for symptomatic hyperviscosity↓ 20–30% per exchange

Plasma viscosity above 4 confirms hyperviscosityviscosity > 4.0 mPa·s

01 · What it isHyperleukocytosis: WBC above 100,000/µL

Hyperleukocytosis is a WBC (blast) count above 100,000/µL; leukostasis is hyperleukocytosis with organ dysfunction — mainly respiratory or neurologic — from blasts plugging the microcirculation, and can occur at lower counts.

02 · DoCytoreduce now with induction chemotherapy

Leukostasis is an emergency (ICU): start induction chemotherapy as soon as possible; hydroxyurea or leukapheresis only bridge, and leukapheresis has not shown a survival benefit.

03 · DoUrgent plasma exchange for symptomatic hyperviscosity

Treat symptomatic paraprotein hyperviscosity with urgent plasma exchange (about 1–1.5 plasma volumes, albumin replacement); one session lowers viscosity 20–30% and rapidly reverses bleeding and neurologic signs. Then start disease therapy.

Causes & risk factors

Why it happens

Waldenström IgM is the classic causeParaprotein hyperviscosity is most common in Waldenström macroglobulinemia (10–30% of patients; large pentameric IgM) and occurs in 2–6% of myeloma, usually IgA or IgG3; IgM of 6 g/dL or more brings rapid onset.

AML causes leukostasis far more than ALLLeukostasis is more frequent in AML — especially monocytic subtypes — than in ALL, because myeloblasts are larger and less deformable; CLL rarely causes it until the WBC exceeds about 1,000,000/µL.

Presentation

What you'll see

Leukostasis: hypoxemia, infiltrates, confusion, blurred vision must knowSuspect leukostasis in leukemia with very high blasts plus dyspnea, hypoxemia or pulmonary infiltrates, or headache, dizziness, tinnitus, blurred vision or altered consciousness; untreated, one-week mortality is about 40%.

Paraprotein hyperviscosity: bleeding, vision, neurologic symptoms must knowParaprotein hyperviscosity causes mucosal bleeding (epistaxis, gums), visual disturbance with sausage-link retinal veins or retinal hemorrhages, and neurologic symptoms from headache and dizziness to seizures or coma.

Expect pseudohyperkalemia and falsely low PaO₂Interpret labs carefully: in-vitro cell lysis causes pseudohyperkalemia (check heparinized plasma potassium), blasts consume oxygen in the sample to give falsely low PaO₂ (use pulse oximetry), and counters may overestimate platelets.

Diagnosis & monitoring

Work-up

Plasma viscosity above 4 confirms hyperviscosityMeasure plasma (serum) viscosity to confirm suspected hyperviscosity: it is usually above 4.0 mPa·s (centipoise) when symptoms are present, versus a normal 1.4–1.8.

Do right now

In this order

First moves

Cytoreduce now with induction chemotherapy

→

Urgent plasma exchange for symptomatic hyperviscosity↓ 20–30% per exchange

→

Hold red cell transfusion until viscosity falls

Why each step

Cytoreduce now with induction chemotherapyLeukostasis is an emergency (ICU): start induction chemotherapy as soon as possible; hydroxyurea or leukapheresis only bridge, and leukapheresis has not shown a survival benefit.

Urgent plasma exchange for symptomatic hyperviscosityTreat symptomatic paraprotein hyperviscosity with urgent plasma exchange (about 1–1.5 plasma volumes, albumin replacement); one session lowers viscosity 20–30% and rapidly reverses bleeding and neurologic signs. Then start disease therapy.

Hold red cell transfusion until viscosity fallsDelay RBC transfusion (and diuretics) until cytoreduction has lowered the WBC or plasma exchange has lowered viscosity — transfusion raises viscosity and can precipitate leukostasis; if essential, transfuse slowly during or after apheresis.

Management

Orders

Do a fundoscopic exam in suspected hyperviscosityExamine the fundi in any patient with a paraprotein and epistaxis or neurologic symptoms: retinal hyperviscosity changes can be present without visual symptoms and are themselves an indication for plasma exchange.

Red flags & don'ts

Avoid harm

No leukapheresis in acute promyelocytic leukemia avoidDo not use leukapheresis in acute promyelocytic leukemia — it can worsen the coagulopathy and raise early death; start ATRA at the first suspicion of APL instead.

Hyperleukocytosis brings tumor lysis and DIC complicationHyperleukocytosis also brings spontaneous or treatment-triggered tumor lysis and DIC (up to 63% when WBC > 100,000/µL): give IV fluids with allopurinol or rasburicase, and replace platelets, fibrinogen and plasma as needed.

Leukostasis or paraprotein hyperviscosity?

Commonly confused

What thickens the blood	Blasts, usually WBC > 100,000/µL (AML > ALL)
Hallmark findings	Hypoxemia, pulmonary infiltrates, confusion, visual change
Emergency treatment	Cytoreduction: induction chemotherapy; hydroxyurea or leukapheresis as a bridge
Red cell transfusion	Hold until the WBC falls

More detail

Reference

Show 5 reference facts

Rituximab can transiently raise IgM (an IgM flare) in 30–70% of Waldenström patients; plasma exchange is advised before rituximab when IgM is 4,000 mg/dL or more or serum viscosity exceeds 3.5 cP.

One leukapheresis session lowers the WBC about 25–50%, but counts rebound because marrow blasts are untouched; citrate anticoagulation can cause hypocalcemia.

Hydroxyurea is a bridging cytoreductive agent when induction must wait (undiagnosed leukemia or contraindications), but its effect is not immediate and it has not shown a mortality benefit.

IgM is about 75% intravascular, so one or two exchanges control Waldenström hyperviscosity; IgG is less intravascular and rebounds, so IgG disease often needs repeated exchanges plus chemotherapy.

In acute monocytic leukemia with respiratory failure, adding dexamethasone 10 mg every 6 hours to chemotherapy lowered ICU mortality versus historical controls (20% vs 50%) without more infections.

Pearl

Cells or proteins — find which one is thickening the blood: cytoreduce blasts, exchange plasma for paraprotein, and hold the red cells either way.

Sources · Ali AM, Mirrakhimov AE, Abboud CN, Cashen AF. Leukostasis in adult acute hyperleukocytic leukemia: a clinician's digest. Hematol Oncol 2016;34:69–78 (open copy read at thebloodproject.com) · Hyperleukocytosis and leukostasis in acute myeloid leukemia. Cells 2020;9:2310 · Leukapheresis and hyperleukocytosis, past and future. Int J Gen Med 2021 (ASFA, ELN recommendations) · Hyperviscosity syndrome in paraprotein secreting conditions including Waldenström macroglobulinemia. Front Oncol 2020;10:815 · Merck Manual Professional — Macroglobulinemia · Starter sheet built from the verified AGACNP fact map (facts reviewed 2026-10-15).